Table 3.

Subjects with specific QTcF values and specific changes from baseline in mean QTcF (dQTcF) for each treatment group

Number of patients (%)
MeasurementGTDS group 1 (N = 60)Intravenous granisetron group 2 (N = 60)Placebo group 3 (N = 60)Moxifloxacin group 4 (N = 60)
QTcF
 >450, ≤480 ms1 (2)3 (5)6 (10)3 (5)
 >480, ≤500 ms0 (0)0 (0)1 (2)0 (0)
 >500 ms0 (0)0 (0)0 (0)0 (0)
dQTcF change
 >30, ≤60 ms1 (2)3 (5)2 (3)1 (2)
 >60 ms0 (0)0 (0)0 (0)0 (0)